Breakthrough study reveals hormonal imbalance behind severe fertility treatment risks

A new study published in Nature Communications sheds light on the causes of Ovarian Hyperstimulation Syndrome (OHSS), a serious complication linked to fertility treatments. Researchers Lai, Huang, and Ma examined how two key hormone receptors—follicle-stimulating hormone (FSHR) and luteinizing hormone (LHR)—contribute to the condition's development. Their findings could change how doctors approach ovarian stimulation in assisted reproduction.

OHSS occurs when the ovaries overreact to hormonal drugs used in fertility treatments. The study found that an imbalance between FSHR and LHR signalling plays a crucial role in triggering the syndrome. When LHR activity weakens, the FSHR pathways become overactive, leading to hyperstimulation. This process boosts the release of vascular endothelial growth factor (VEGF), which increases blood vessel permeability—a key feature of OHSS.

The researchers also discovered that excessive LHR activity can cause harmful responses. This highlights the need for a precise balance between the two receptors. Under certain stimulation protocols, disrupted expression and activation of FSHR and LHR worsen ovarian hyperactivation, raising the risk of OHSS. Based on these insights, the team proposed adjustments to current hormonal stimulation methods. They suggest fine-tuning drug regimens to prevent receptor imbalances and reduce hyperstimulation. Additionally, the study introduces potential pharmacological treatments that target the interaction between FSHR and LHR, aiming to prevent or manage OHSS without reducing the effectiveness of ovarian stimulation.

The findings offer a clearer understanding of OHSS and its connection to hormone receptor dynamics. Beyond fertility treatments, the research may also impact the management of other reproductive disorders, including polycystic ovary syndrome (PCOS) and premature ovarian failure. Clinicians could soon use these discoveries to refine treatment protocols and improve patient safety.